BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
The provision of vaccines to protect against combined diphtheria, tetanus, and pertussis vaccines, with and without additional poliomyelitis antigen content, to be used in the national immunisation programme. Deliveries will be required over the initial term of 2 years and the contract has the option to be extended for up to an additional 24 months.
Value - The contract value is withheld from publication pursuant to regulation 50(6)(b) of the Public Contracts Regulations 2015 (as amended) so as not to prejudice the legitimate commercial interest of the supplier.
| Supplier | Identifier | Award Value | Cross-References |
|---|---|---|---|
| DUPLICATE - Aventis Pharma Ltd Trading As Sanofi | - | £1 | - |